BC Cancer Agency

Pacylex Pharmaceuticals Announces the Initiation of a Phase 1 Clinical of PCLX-001, a First-In-Class NMT Inhibitor, in Non-Hodgkin's Lymphomas and Solid Tumor Patients

Tuesday, September 14, 2021 - 9:13pm

Edmonton, Alberta--(Newsfile Corp. - September 14, 2021) - To view the full announcement, including downloadable images, bios, and more, click here .

Key Points: 
  • Edmonton, Alberta--(Newsfile Corp. - September 14, 2021) - To view the full announcement, including downloadable images, bios, and more, click here .
  • PCLX-001 is the first clinical candidate sponsored by Pacylex Pharmaceuticals to reach the clinical stage.
  • Upcoming enrollment of 20-30 patients to begin at the Cross Cancer Institute in Edmonton and expand to Princess Margaret Hospital in Toronto and the BC Cancer Agency in Vancouver.
  • This open label, dose escalation study will examine the safety and tolerability of PCLX-001.

Valvoline Instant Oil Change raises over $66,500 for cancer research and patient care at Dana-Farber Cancer Institute

Tuesday, September 24, 2019 - 3:23pm

The Jimmy Fund solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world.

Key Points: 
  • The Jimmy Fund solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world.
  • "Dana-Farber is one of the leading cancer institutes in the world, and the work they do to support cancer research and care is remarkable," said Don Smith, CEO of the Valvoline Instant Oil Change franchisee, Henley Enterprises.
  • Every dollar truly makes a huge impact on compassionate patient care and ground-breaking research being done at the institute."
  • The Jimmy Fund ( www.JimmyFund.org ) solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world.

New home for nuclear medicine at the University of British Columbia

Thursday, November 1, 2018 - 10:47pm

The Prime Minister, Justin Trudeau, today announced federal funding to build a new home for nuclear medicine at TRIUMF.

Key Points: 
  • The Prime Minister, Justin Trudeau, today announced federal funding to build a new home for nuclear medicine at TRIUMF.
  • Investing in science and innovation is a key driver of jobs and growth, and essential to building a modern, resilient economy for Canadians.
  • Investing in the front lines of the fight against cancer will give life and hope to people here in British Columbia and around the world."
  • The Province of British Columbia has contributed $12,250,000, TRIUMF is contributing $5,352,638 and, through fundraising initiatives, BC Cancer and the University of British Columbia are each contributing $2 million.